Cumulative effects of irreversible MAO inhibitors in vivo.
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology; D003010:Clorgyline / Q000494:pharmacology; D005260:Female; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010293:Pargyline / Q000494:pharmacology; D010627:Phenethylamines / Q000378:metabolism; D051381:Rats; D012642:Selegiline / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism; D013997:Time Factors; D014191:Tranylcypromine / Q000494:pharmacology
D008996:Monoamine Oxidase Inhibitors; D010627:Phenethylamines; D012642:Selegiline; D012701:Serotonin; D014191:Tranylcypromine; D010293:Pargyline; D003010:Clorgyline